A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Stella
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(219 sites)
United States
Disney Family Cancer Center, Burbank, California
Scripps Health, La Jolla, California
Cancer and Blood Specialty Clinic, Los Alamitos, California
Ellison Institute of Technology, Los Angeles, California
Palo Alto Medical Foundation Research Center, Palo Alto, California
Kaiser Permanente - San Marcos, San Marcos, California
Palo Alto Medical Foundation Research Center, San Mateo, California
Palo Alto Medical Foundation Research Center, Sunnyvale, California
Cancer Specialists of North Florida - Jacksonville, Jacksonville, Florida
Tallahassee Memorial HealthCare, Tallahassee, Florida
Moffitt Cancer Center-McKinley Campus, Tampa, Florida
Northwest Georgia Oncology Centers PC - Marietta, Marietta, Georgia
Cancer Care Specialists of Central Illinois, O'Fallon, Illinois
Argentina
Centro Oncologico Korben, Caba
Centro Médico Fleischer, Capital Federal
Hospital Privado Centro Medico de Cordoba, Córdoba
Instituto de Oncologia de Rosario, Rosario
Centro Oncológico de Excelencia, San Juan
Australia
Royal North Shore Hospital, St Leonards, New South Wales
Lyell McEwin Hospital, Elizabeth Vale, South Australia
Brazil
Crio - Centro Regional Integrado de Oncologia, Fortaleza, Ceará
Hospital Santa Rita de Cassia Vitoria, Vitória, Espírito Santo
Obras Sociais Irma Dulce - Osid, Salvador, Estado de Bahia
Hospital Araujo Jorge, Goiânia, Goiás
Centro de Oncologia de Alfenas, Alfenas, Minas Gerais
Hospital do Câncer de Londrina, Londrina, Paraná
Hospital do Cancer de Pernambuco - HCP, Recife, Pernambuco
Vencer Oncoclínica - Centro de Pesquisa do Piauí, Teresina, Piauí
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul
Hospital de Cancer de Barretos, Barretos, São Paulo
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, São Paulo
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo, São Paulo
Canada
Arthur J.E. Child Comprehensive Cancer Center, Calgary, Alberta
Cross Cancer Institute, Edmonton, Alberta
CancerCare Manitoba, Winnipeg, Manitoba
The Moncton Hospital, Moncton, New Brunswick
The Ottawa Hospital Cancer Center, Ottawa, Ontario
Sault Area Hospital, Sault Ste. Marie, Ontario
Sunnybrook Health Sciences Centre, Toronto, Ontario
St. Joseph's Health Centre, Toronto, Ontario
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec
Jewish General Hospital, Montreal, Quebec
Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec
Unité de Recherche Clinique du CISSS de Laurentides, Saint-Jérôme, Quebec
China
Xiangyang Central Hospital, Xiangyang, Hubei
Peking Union Medical College Hospital, Beijing
Hunan Cancer Hospital, Changsha
West China Hospital of Sichuan University, Chengdu
Sichuan Provincial People's Hospital, Chengdu
Sun yat-sen University Cancer Center, Guangzhou
Sun Yat-Sen University Cancer Center - Huangpu Campus, Guangzhou
Zhejiang Cancer Hospital, Hangzhou
Harbin Medical University Cancer Hospital, Harbin
Jiangmen Central Hospital, Jiangmen
Shandong Cancer Hospital, Jinan
Jinhua municipal central hospital, Jinhua
Yunnan Cancer Hospital, Kunming
France
ICO Paul Papin, Angers
Centre Oscar Lambret, Lille
Centre Cancerologie Grand Montpellier, Montpellier
INSTITUT CURIE_SITE PARIS - Service d'Oncologie Médicale., Paris